87 related articles for article (PubMed ID: 38466642)
1. COP9 signalosome complex is a prognostic biomarker and corresponds with immune infiltration in hepatocellular carcinoma.
Liu J; Han D; Xuan J; Xie J; Wang W; Zhou Q; Chen K
Aging (Albany NY); 2024 Mar; 16(6):5264-5287. PubMed ID: 38466642
[TBL] [Abstract][Full Text] [Related]
2. Analysis of expression profiles and prognostic value of COP9 signalosome subunits for patients with head and neck squamous cell carcinoma.
Zhou H; Sun W; Zou J
Oncol Lett; 2021 Nov; 22(5):803. PubMed ID: 34630710
[TBL] [Abstract][Full Text] [Related]
3. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
4. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
6. Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma.
Liu T; Li ZZ; Sun L; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P
BMC Cancer; 2023 Oct; 23(1):1007. PubMed ID: 37858061
[TBL] [Abstract][Full Text] [Related]
7. Integrated omics landscape of hepatocellular carcinoma suggests proteomic subtypes for precision therapy.
Xing X; Hu E; Ouyang J; Zhong X; Wang F; Liu K; Cai L; Zhou Y; Wang Y; Chen G; Li Z; Wu L; Liu X
Cell Rep Med; 2023 Dec; 4(12):101315. PubMed ID: 38091986
[TBL] [Abstract][Full Text] [Related]
8. Proteome Landscapes of Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Yi X; Zhu J; Liu W; Peng L; Lu C; Sun P; Huang L; Nie X; Huang S; Guo T; Zhu Y
Mol Cell Proteomics; 2023 Aug; 22(8):100604. PubMed ID: 37353004
[TBL] [Abstract][Full Text] [Related]
9. Nascent Proteome and Glycoproteome Reveal the Inhibition Role of ALG1 in Hepatocellular Carcinoma Cell Migration.
Cao X; Shao Y; Meng P; Cao Z; Yan G; Yao J; Zhou X; Liu C; Zhang L; Shu H; Lu H
Phenomics; 2022 Aug; 2(4):230-241. PubMed ID: 36939752
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Expression and Prognostic Value of the TCP1 Ring Complex in Hepatocellular Carcinoma and Overexpressing Its Subunit 5 Promotes HCC Tumorigenesis.
Liu J; Huang L; Zhu Y; He Y; Zhang W; Lei T; Xuan J; Xiao B; Li L; Zhou Q; Sun Z
Front Oncol; 2021; 11():739660. PubMed ID: 34676169
[TBL] [Abstract][Full Text] [Related]
11. The potential oncogenic and MLN4924-resistant effects of CSN5 on cervical cancer cells.
Zhang H; He P; Zhou Q; Lu Y; Lu B
Cancer Cell Int; 2021 Jul; 21(1):369. PubMed ID: 34247597
[TBL] [Abstract][Full Text] [Related]
12. COPS8 in cutaneous melanoma: an oncogene that accelerates the malignant development of tumor cells and predicts poor prognosis.
Sun L
Biosci Biotechnol Biochem; 2021 Feb; 85(2):242-250. PubMed ID: 33604618
[TBL] [Abstract][Full Text] [Related]
13. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
